Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000377821 | SCV000333723 | pathogenic | not provided | 2015-09-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000532444 | SCV000649660 | pathogenic | Qualitative or quantitative defects of dysferlin | 2023-03-17 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 282316). This premature translational stop signal has been observed in individual(s) with dysferlinopathy (PMID: 27647186). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ala115Profs*36) in the DYSF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480). |
Ce |
RCV000377821 | SCV001246778 | pathogenic | not provided | 2018-10-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002502101 | SCV002807596 | likely pathogenic | Miyoshi muscular dystrophy 1; Autosomal recessive limb-girdle muscular dystrophy type 2B; Distal myopathy with anterior tibial onset | 2022-05-12 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003469224 | SCV004192280 | pathogenic | Miyoshi muscular dystrophy 1 | 2024-03-02 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000593550 | SCV000790869 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2017-04-12 | no assertion criteria provided | clinical testing |